Lawrence Pemble
Directeur des opérations chez CannBioRex Pharmaceuticals Corp.
Postes actifs de Lawrence Pemble
Sociétés | Poste | Début | Fin |
---|---|---|---|
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | 01/04/2018 | - |
Directeur des opérations | 01/05/2018 | - | |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - | - |
Directeur des opérations | - | - | |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Directeur des opérations | - | - |
Historique de carrière de Lawrence Pemble
Anciens postes connus de Lawrence Pemble
Sociétés | Poste | Début | Fin |
---|---|---|---|
AUSCAN RESOURCES INC. | Directeur/Membre du Conseil | 04/12/2017 | 09/11/2021 |
Directeur Général | 10/10/2018 | 05/06/2019 | |
Directeur des opérations | 04/12/2017 | 05/06/2019 | |
Directeur Financier/CFO | 04/12/2017 | 05/06/2019 | |
Secrétaire Général | 04/12/2017 | 05/06/2019 | |
GLOBAL GAMING TECHNOLOGIES CORP. | Directeur/Membre du Conseil | 18/04/2019 | 15/08/2019 |
HEMOGENYX PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 01/10/2017 | 05/11/2018 |
Directeur des opérations | 01/10/2017 | 05/11/2018 | |
GRAY FOX PETROLEUM CORP | Directeur/Membre du Conseil | 31/05/2013 | 02/04/2015 |
Directeur Général | 31/05/2013 | 02/04/2015 | |
Directeur Financier/CFO | 31/05/2013 | 29/05/2014 | |
President | 31/05/2013 | 02/04/2015 | |
Secrétaire Général | 31/05/2013 | 02/04/2015 | |
Treasurer | 31/05/2013 | 02/04/2015 | |
180 LIFE SCIENCES CORP. | Directeur des opérations | - | - |
Statistiques
Internationale
Canada | 6 |
Etats-Unis | 3 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 6 |
Chief Operating Officer | 6 |
Chief Executive Officer | 2 |
Sectorielle
Health Technology | 5 |
Process Industries | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
HEMOGENYX PHARMACEUTICALS PLC | Health Technology |
AUSCAN RESOURCES INC. | Process Industries |
GLOBAL GAMING TECHNOLOGIES CORP. | Finance |
180 LIFE SCIENCES CORP. | Health Technology |
Entreprise privées | 4 |
---|---|
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Health Technology |
Grey Fox Holdings Corp.
Grey Fox Holdings Corp. RestaurantsConsumer Services Grey Fox Holdings Corp. was engaged in the acquisition of revenue generating subsidiaries to increase company revenues and shareholder value. The company was founded by Viatcheslav Gelshteyn on September 22, 2011 and was headquartered in Longwood, FL. | Consumer Services |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Health Technology |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Health Services |
- Bourse
- Insiders
- Lawrence Pemble
- Expérience